Heart failure in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation

European Journal of Heart Failure

Volumn 17, Issue 6, 2015, Pages 570-582

  Lip, Gregory Y H ^a   Laroche, Cécile ^b   Popescu, Mircea I ^c   Rasmussen, Lars H ^d   Vitali Serdoz, Laura ^e   Dan, Gheorghe Andrei ^f   Kalarus, Zbigniew ^g   Crijns, Harry J G M ^h   Oliveira, Mario M ⁱ   Tavazzi, Luigi ^j   Maggioni, Aldo P ^b   Boriani, Giuseppe ^k,l  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b European Society of Cardiology   (France)

^c Clinic of Diabetes and Internal Diseases   (Romania)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF TRIESTE   (Italy)

^f CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^g MEDICAL UNIVERSITY OF SILESIA   (Poland)

^h MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY OF LISBON   (Portugal)

^j MARIA CECILIA HOSPITAL   (Italy)

^k UNIVERSITY OF BOLOGNA   (Italy)

^l AALBORG UNIVERSITY   (Denmark)

more..

Author keywords

Atrial fibrillation; Heart failure; Registry

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DABIGATRAN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RIVAROXABAN; ANTICOAGULANT AGENT;

ABNORMAL BLOOD PRESSURE; ADULT; AGE; AGED; ANGINA PECTORIS; ATRIAL FIBRILLATION; BODY MASS; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR MORTALITY; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CHA2DS2 VASC SCORE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EUROPE; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; QRS INTERVAL; QUALITY OF LIFE; REVIEW; SHORT QT INTERVAL; SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; VALVULAR HEART DISEASE; HEART STROKE VOLUME; MIDDLE AGED; PHYSIOLOGY; PILOT STUDY; REGISTER;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; EUROPE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; REGISTRIES; STROKE VOLUME;

EID: 84931574459     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.254     Document Type: Review

References (20)

1. Lau YC, Lane DA, Lip GY,. Atrial fibrillation and heart failure: a bad combination. Am J Cardiol 2014; 113: 1196-1197.
2. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P,. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14: 803-869.
3. Lip GY, Rasmussen LH, Skjoth F, Overvad K, Larsen TB,. Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study. BMJ Open 2012; 2:pii: e000975.
4. Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Oliveira MM, Mairesse G, Crijns HJ, Simantirakis E, Atar D, Kirchhof P, Vardas P, Tavazzi L, Maggioni AP,. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Europace 2014; 16: 308-319.
5. Badia X, Arribas F, Ormaetxe JM, Peinado R, de Los Terreros MS,. Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL). Health Qual Life Outcomes 2007; 5: 37.
6. Arribas F, Ormaetxe JM, Peinado R, Perulero N, Ramirez P, Badia X,. Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation. Europace 2010; 12: 364-370.
7. Khazanie P, Liang L, Qualls LG, Curtis LH, Fonarow GC, Hammill BG, Hammill SC, Heidenreich PA, Masoudi FA, Hernandez AF, Piccini JP,. Outcomes of medicare beneficiaries with heart failure and atrial fibrillation. JACC Heart Fail 2014; 2: 41-48.
8. Nieuwlaat R, Eurlings LW, Cleland JG, Cobbe SM, Vardas PE, Capucci A, Lopez-Sendon JL, Meeder JG, Pinto YM, Crijns HJ,. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation. J Am Coll Cardiol 2009; 53: 1690-1698.
9. Lip GY,. The role of aspirin for stroke prevention in atrial fibrillation. Nat Rev Cardiol 2011; 8: 602-606.
10. Chatterjee S, Ghosh J, Lichstein E, Aikat S, Mukherjee D,. Meta-analysis of cardiovascular outcomes with dronedarone in patients with atrial fibrillation or heart failure. Am J Cardiol 2012; 110: 607-613.
11. Swedberg K, Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Shi H, Vincent J, Pitt B, Investigators E-HS. Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study. J Am Coll Cardiol 2012; 59: 1598-1603.
12. Oktay AA, Shah SJ,. Current perspectives on systemic hypertension in heart failure with preserved ejection fraction. Curr Cardiol Rep 2014; 16: 545.
13. Dhingra A, Garg A, Kaur S, Chopra S, Batra JS, Pandey A, Chaanine AH, Agarwal SK,. Epidemiology of heart failure with preserved ejection fraction. Curr Heart Fail Rep 2014; 11: 354-365.
14. Taillandier S, Brunet Bernard A, Lallemand B, Simeon E, Pericart L, Clementy N, Babuty D, Fauchier L,. Prognosis in patients hospitalized with permanent and nonpermanent atrial fibrillation in heart failure. Am J Cardiol 2014; 113: 1189-1195.
15. Lubitz SA, Moser C, Sullivan L, Rienstra M, Fontes JD, Villalon ML, Pai M, McManus DD, Schnabel RB, Magnani JW, Yin X, Levy D, Pencina MJ, Larson MG, Ellinor PT, Benjamin EJ,. Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community. J Am Heart Assoc 2013; 2: e000126.
16. McManus DD, Hsu G, Sung SH, Saczynski JS, Smith DH, Magid DJ, Gurwitz JH, Goldberg RJ, Go AS, Cardiovascular Research Network PS. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc 2013; 2: e005694.
17. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P,. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace 2012; 14: 1385-413.
18. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI,. Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position Paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost 2013; 110: 1087-1107.
19. Gallego P, Roldan V, Marin F, Romera M, Valdes M, Vicente V, Lip GY,. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thromb Haemost 2013; 110: 1189-1198.
20. Hart RG, Pearce LA, Aguilar MI,. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867.